However, as explained in Part 1 of this series on KPMG’s Technology Strategy and Selection (TSS) framework, that outlook often does not drive the outcomes or the value that companies are expecting.

In a recent paper, Uma Lakshmipathy, PhD, senior director of R&D, Thermo Fisher Scientific, and colleagues outline a framework to guide the selection and deployment of cell therapy processing ...